Loading organizations...
Key people at Uniquest.
UniQuest specializes in the commercialization of academic research, transforming world-class university discoveries into viable market solutions. It identifies intellectual property generated within universities and applies its extensive technical and market expertise to develop and transfer these innovations. The organization's core function is to bridge the critical gap between scientific advancement and practical commercial application.
Established in 1984 by The University of Queensland, UniQuest emerged from a strategic vision to unlock the significant commercial potential inherent in academic research. This foundational initiative aimed to facilitate the translation of university-generated knowledge and inventions into tangible outcomes, ensuring groundbreaking studies contributed beyond scholarly publications to achieve broader societal and economic benefits.
UniQuest serves diverse stakeholders, including industries seeking advanced technological solutions and investors interested in backing early-stage, research-backed ventures. The company’s overarching mission is to accelerate the path of university innovations from the laboratory to global markets, thereby maximizing their overall impact and fostering a vibrant ecosystem of research-driven commercialization.
Key people at Uniquest.
Uniquest has 6 tracked investments across 5 companies. The latest tracked deal is $2.4M Seed in VeriQuantix in October 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 23, 2025 | VeriQuantix | $2.4M Seed | Uniseed | Lucerne Investment Partners, Powerhouse Ventures |
| Sep 1, 2025 | Optain | $26.0M Series A | Insight Partners | Afore Capital, Antiportfolio Ventures, Crossbeam Venture Partners, Overlooked Ventures, Right Side Capital Management, Stone Mountain Ventures, Evan Moore, Informed Ventures, Lumio Capital, Memorial Hermann Health System, Meridian Ventures, Northwell Health, Novant Health, The Ohio State University, UPMC |
| Dec 5, 2022 | Vaxxas | $23.1M Other Equity | Paul Kelly, Uniquest | — |
| Sep 9, 2016 | LifeSignals | $10.2M Series C | — | Tuff YEN, Michael Borrus |
| Apr 1, 2014 | Spinifex Pharmaceuticals | $45.0M Series C | Heath Lukatch | Brandon Capital Partners, Canaan Partners, RED Tree Venture Capital, Brandon Capital, Brent Ahrens, GBS Venture Partners, Uniseed |
| Aug 1, 2011 | Spinifex Pharmaceuticals | $19.0M Series B | — | Brandon Capital Partners, Brandon Capital, GBS Venture Partners, Uniseed |